GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Cyclically Adjusted Revenue per Share

Bausch Health (FRA:BVF) Cyclically Adjusted Revenue per Share : €25.57 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bausch Health's adjusted revenue per share for the three months ended in Mar. 2024 was €5.400. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €25.57 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bausch Health's average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bausch Health was 24.90% per year. The lowest was 4.10% per year. And the median was 12.25% per year.

As of today (2024-05-14), Bausch Health's current stock price is €6.65. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €25.57. Bausch Health's Cyclically Adjusted PS Ratio of today is 0.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 27.37. The lowest was 0.17. And the median was 1.26.


Bausch Health Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted Revenue per Share Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.47 17.14 22.13 23.85 25.28

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.67 25.39 25.68 25.28 25.57

Competitive Comparison of Bausch Health's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.



Bausch Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.4/125.4675*125.4675
=5.400

Current CPI (Mar. 2024) = 125.4675.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.402 99.473 5.552
201409 4.675 99.394 5.901
201412 5.273 98.367 6.726
201503 5.839 99.789 7.342
201506 7.069 100.500 8.825
201509 7.074 100.421 8.838
201512 7.266 99.947 9.121
201603 6.176 101.054 7.668
201606 6.243 102.002 7.679
201609 6.320 101.765 7.792
201612 6.514 101.449 8.056
201703 5.626 102.634 6.878
201706 5.677 103.029 6.913
201709 5.285 103.345 6.416
201712 5.178 103.345 6.286
201803 4.613 105.004 5.512
201806 5.185 105.557 6.163
201809 5.208 105.636 6.186
201812 5.298 105.399 6.307
201903 5.079 106.979 5.957
201906 5.409 107.690 6.302
201909 5.692 107.611 6.636
201912 5.675 107.769 6.607
202003 5.152 107.927 5.989
202006 4.159 108.401 4.814
202009 5.073 108.164 5.885
202012 5.111 108.559 5.907
202103 4.772 110.298 5.428
202106 4.863 111.720 5.461
202109 4.930 112.905 5.479
202112 5.397 113.774 5.952
202203 4.827 117.646 5.148
202206 5.137 120.806 5.335
202209 5.686 120.648 5.913
202212 5.709 120.964 5.922
202303 4.998 122.702 5.111
202306 5.448 124.203 5.503
202309 5.739 125.230 5.750
202312 6.032 125.468 6.032
202403 5.400 125.468 5.400

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bausch Health  (FRA:BVF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.65/25.57
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 27.37. The lowest was 0.17. And the median was 1.26.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bausch Health Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (FRA:BVF) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines